149 related articles for article (PubMed ID: 33295334)
21. Prevalence and repair of intraoperatively diagnosed patent foramen ovale and association with perioperative outcomes and long-term survival.
Krasuski RA; Hart SA; Allen D; Qureshi A; Pettersson G; Houghtaling PL; Batizy LH; Blackstone E
JAMA; 2009 Jul; 302(3):290-7. PubMed ID: 19602688
[TBL] [Abstract][Full Text] [Related]
22. Impact of national lockdown towards emergency department visits and admission rates during the COVID-19 pandemic in Thailand: A hospital-based study.
Wongtanasarasin W; Srisawang T; Yothiya W; Phinyo P
Emerg Med Australas; 2021 Apr; 33(2):316-323. PubMed ID: 33070468
[TBL] [Abstract][Full Text] [Related]
23. Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MR.
Patzelt J; Ulrich M; Becker A; Müller KAL; Jorbenadze R; Droppa M; Zhang W; Mandel S; Habel L; Lausberg H; Pöss J; Geisler T; Borst O; Rosenberger P; Schlensak C; Gawaz M; Schreieck J; Seizer P; Langer HF
PLoS One; 2018; 13(10):e0205930. PubMed ID: 30339701
[TBL] [Abstract][Full Text] [Related]
24. Transcatheter Aortic Valve Implantation During the COVID-19 Pandemic.
Valdebenito M; Massalha E; Barbash IM; Maor E; Fefer P; Guetta V; Segev A
Am J Cardiol; 2021 Apr; 145():97-101. PubMed ID: 33454341
[TBL] [Abstract][Full Text] [Related]
25. Unexpected peak of mortality: The COVID-19 burden on Bergamo transcatheter aortic valve implantation register.
Cereda A; Cugola D; Balestrieri G; Vassileva A; Valsecchi O
Anatol J Cardiol; 2020 Sep; 24(3):209-210. PubMed ID: 32870164
[No Abstract] [Full Text] [Related]
26. Structural Heart Interventions During COVID-19.
Obi K; Baldawi H; Garba S; Amoran O; Jenkins C; Gillies C; Penfold D; Dengle S; Alocozy L; Falloon A; Bob-Manuel T
Curr Probl Cardiol; 2022 Feb; 47(2):100934. PubMed ID: 34384618
[TBL] [Abstract][Full Text] [Related]
27. Comment on the article "Simultaneous percutaneous closure of patent foramen ovale and left atrial appendage".
Hernández-Estefanía R; Levy-Praschker B; Rábago G
Rev Esp Cardiol (Engl Ed); 2012 Mar; 65(3):299; author reply 300. PubMed ID: 22112391
[No Abstract] [Full Text] [Related]
28. The rush to atrial septal defect closure: is the introduction of percutaneous closure driving utilization?
Karamlou T; Diggs BS; Ungerleider RM; McCrindle BW; Welke KF
Ann Thorac Surg; 2008 Nov; 86(5):1584-90; discussion 1590-1. PubMed ID: 19049754
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular procedural deferral and outcomes over COVID-19 pandemic phases: A multi-center study.
Yong CM; Spinelli KJ; Chiu ST; Jones B; Penny B; Gummidipundi S; Beach S; Perino A; Turakhia M; Heidenreich P; Gluckman TJ
Am Heart J; 2021 Nov; 241():14-25. PubMed ID: 34181910
[TBL] [Abstract][Full Text] [Related]
30. Association of Hospital Inpatient Percutaneous Coronary Intervention Volume With Clinical Outcomes After Transcatheter Aortic Valve Replacement and Transcatheter Mitral Valve Repair.
Butala NM; Bucholz EM; Kolte D; Elmariah S
JAMA Cardiol; 2020 Apr; 5(4):464-468. PubMed ID: 32049303
[TBL] [Abstract][Full Text] [Related]
31. Permanent right-to-left shunt is the key factor in managing patent foramen ovale.
Rigatelli G; Dell'Avvocata F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Mandapaka S; Kuruvilla J; Chen JP; Nanjundappa A
J Am Coll Cardiol; 2011 Nov; 58(21):2257-61. PubMed ID: 22078434
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
Van de Bruaene A; Stroobants D; Benit E
Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
[TBL] [Abstract][Full Text] [Related]
33. Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures.
Guedeney P; Hammoudi N; Duthoit G; Yan Y; Silvain J; Pousset F; Isnard R; Redheuil A; Kerneis M; Collet JP; Montalescot G
EuroIntervention; 2017 Nov; 13(10):1226-1233. PubMed ID: 28804058
[TBL] [Abstract][Full Text] [Related]
34. Transseptal puncture versus patent foramen ovale or atrial septal defect access for left atrial appendage closure.
Kleinecke C; Fuerholz M; Buffle E; de Marchi S; Schnupp S; Brachmann J; Nietlispach F; Fankhauser M; Streit SR; Windecker S; Meier B; Gloekler S
EuroIntervention; 2020 Jun; 16(2):e173-e180. PubMed ID: 31449043
[TBL] [Abstract][Full Text] [Related]
35. Early Impact of the COVID-19 Pandemic on Congenital Heart Surgery Programs Across the World: Assessment by a Global Multi-Societal Consortium.
Protopapas EM; Rito ML; Vida VL; Sarris GE; Tchervenkov CI; Maruszewski BJ; Tobota Z; Zheleva B; Zhang H; Jacobs JP; Dearani JA; Stephens EH; Tweddell JS; Sandoval NF; Bacha EA; Austin EH; Sakamoto K; Talwar S; Kurosawa H; Halees ZYA; Jatene MB; Iyer KS; Lee C; Sharma R; Hirata Y; Edwin F; Cervantes JL; O'Brien J; St Louis J; Kirklin JK;
World J Pediatr Congenit Heart Surg; 2020 Nov; 11(6):689-696. PubMed ID: 32844725
[TBL] [Abstract][Full Text] [Related]
36. Reduction of admissions for urgent and elective pacemaker implant during the COVID-19 outbreak in Northern Italy.
Dell'Era G; Colombo C; Forleo GB; Curnis A; Marcantoni L; Racheli M; Sartori P; Notarstefano P; De Salvia A; Guerra F; Ziacchi M; Tondo C; Gandolfi E; De Vecchi F; Mascioli G; Coppolino A; Catuzzo B; Amellone C; Mantica M; D'Ascenzo F; Patti G
J Cardiovasc Med (Hagerstown); 2022 Jan; 23(1):22-27. PubMed ID: 34545009
[TBL] [Abstract][Full Text] [Related]
37. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement.
Shah PB; Welt FGP; Mahmud E; Phillips A; Kleiman NS; Young MN; Sherwood M; Batchelor W; Wang DD; Davidson L; Wyman J; Kadavath S; Szerlip M; Hermiller J; Fullerton D; Anwaruddin S
Catheter Cardiovasc Interv; 2020 Sep; 96(3):659-663. PubMed ID: 32251546
[TBL] [Abstract][Full Text] [Related]
38. Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale.
Merkler AE; Gialdini G; Yaghi S; Okin PM; Iadecola C; Navi BB; Kamel H
Stroke; 2017 Nov; 48(11):3073-3077. PubMed ID: 28939677
[TBL] [Abstract][Full Text] [Related]
39. Guidelines for Balancing Priorities in Structural Heart Disease During the COVID-19 Pandemic.
Khan JM; Khalid N; Shlofmitz E; Forrestal BJ; Yerasi C; Case BC; Chezar-Azerrad C; Musallam A; Rogers T; Waksman R
Cardiovasc Revasc Med; 2020 Aug; 21(8):1030-1033. PubMed ID: 32736981
[TBL] [Abstract][Full Text] [Related]
40. Facing SARS-CoV-2 Pandemic at a COVID-19 Regional Children's Hospital in Italy.
Ciofi Degli Atti ML; Campana A; Muda AO; Concato C; Ravà L; Ricotta L; Reale A; Barbieri M; D'Argenio P; Lancella L; Villani A; Raponi M
Pediatr Infect Dis J; 2020 Sep; 39(9):e221-e225. PubMed ID: 32639459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
